MDXG
NASDAQ · Biotechnology
Mimedx Group Inc
$4.10
-0.06 (-1.44%)
Open$4.18
Previous Close$4.16
Day High$4.21
Day Low$4.05
52W High$7.97
52W Low$3.03
Volume—
Avg Volume1.99M
Market Cap632.60M
P/E Ratio101.39
EPS$0.04
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+489.0% upside
Current
$4.10
$4.10
Target
$24.15
$24.15
$19.42
$24.15 avg
$35.38
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 431.40M | 371.71M | 190.63M |
| Net Income | 50.05M | 38.81M | 27.70M |
| Profit Margin | 11.6% | 11.0% | 14.5% |
| EBITDA | 67.29M | 55.08M | 34.17M |
| Free Cash Flow | — | — | 29.04M |
| Rev Growth | +16.1% | +16.1% | +8.9% |
| Debt/Equity | 0.07 | 0.07 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |